Determination of the subset of Sjögren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies

Journal of Rheumatology

Volumn 36, Issue 1, 2009, Pages 113-115

  Iwamoto, Naoki ^a   Kawakami, Atsushi ^a   Tamai, Mami ^a   Fujikawa, Keita ^a   Arima, Kazuhiko ^a   Aramaki, Toshiyuki ^a   Kawashiri, Shinya ^a   Ichinose, Kunihiro ^a   Kamachi, Makoto ^a   Nakamura, Hideki ^a   Origuchi, Tomoki ^a   Ida, Hiroaki ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Anticyclic citrullinated peptide antibodies; Articular manifestations; Sj gren's syndrome

Indexed keywords

ANTICYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LA ANTIBODY; PEPTIDE ANTIBODY; RHEUMATOID FACTOR; RO ANTIBODY; UNCLASSIFIED DRUG; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; IMMUNOGLOBULIN M; SS A ANTIBODIES; SS B ANTIBODIES; SS-A ANTIBODIES; SS-B ANTIBODIES;

ADULT; ARTHRALGIA; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; JAPANESE; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; AGED; BLOOD; CLASSIFICATION; EPIDEMIOLOGY; IMMUNOLOGY; JAPAN; MIDDLE AGED; PREDICTION AND FORECASTING;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; FEMALE; HUMANS; IMMUNOGLOBULIN M; JAPAN; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PREDICTIVE VALUE OF TESTS; RHEUMATOID FACTOR; SEROEPIDEMIOLOGIC STUDIES; SJOGREN'S SYNDROME;

EID: 58149526650     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080193     Document Type: Article

References (7)

1. Pease CT, Shattles W, Barrett NK, et al. Clinical review: The arthropathy of Sjögren's syndrome. Br J Rheumatol 1993;32:606-13.
2. Nakamura H, Kawakami A, Eguchi K, et al. Clinical significance of anti-citrullinated peptide antibody in Japanese patients with established rheumatoid arthritis. Scand J Rheumatol 2005;34:489-95.
3. Vitali C, Bombardieri S, Jonsson R, et al, and the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome. Ann Rheum Dis 2002;61:554-8.
4. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
5. Berglin E, Johansson T, Sundin A, et al. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis 2006;65:453-8.
6. Gottenberg J-E, Mignot S, Nicaise P, et al. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome. Ann Rheum Dis 2005;64:114-7.
7. Rantapaa-Dahlqvist SR, de Jong BA, Berglin E, et al. Antibodies against citrullinated peptides and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9.